UGT3A2 anticorps (N-Term)
Aperçu rapide pour UGT3A2 anticorps (N-Term) (ABIN630444)
Antigène
Voir toutes UGT3A2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- UGT3 A2 antibody was raised against the N terminal of µgT3 2
-
Purification
- Purified
-
Immunogène
- UGT3 A2 antibody was raised using the N terminal of µgT3 2 corresponding to a region with amino acids HNVTMLNHKRGPFMPDFKKEEKSYQVISWLAPEDHQREFKKSFDFFLEET
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
UGT3A2 Blocking Peptide, (ABIN939190), is also available for use as a blocking control in assays to test for specificity of this µgT3A2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of µgT0 2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UGT3A2 (UDP Glycosyltransferase 3 Family, Polypeptide A2 (UGT3A2))
-
Autre désignation
- UGT3A2
-
Sujet
- UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.
-
Poids moléculaire
- 59 kDa (MW of target protein)
Antigène
-